Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02017912 |
|---|---|
| Brief Title: | Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS (NurOwn) |
| First Submitted : | December 17, 2013 |
| First Submitted that Met QC Criteria : | December 17, 2013 |
| First Posted : | December 23, 2013 (Estimate) |
| Certification/Extension First Submitted : | July 15, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | July 15, 2018 |
| Certification/Extension First Posted : | July 18, 2018 |
| Last Update Submitted that Met QC Criteria : | July 15, 2018 |
| Last Update Posted : | July 18, 2018 |